MODIFICATION OF ASSAYS FOR THE ROUTINE ANALYSIS OF 3-METHOXY-4-HYDROXYPHENYLGLYCOL IN URINE BY ELECTRON-CAPTURE GAS CHROMATOGRAPHYLOMBROZO L; ANDERSON TJ; KANASKE K et al.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 181; NO 1; PP. 1-10; BIBL. 9 REF.Article

MARIHUANA METABOLITES IN URINE OF MAN. VI. SEPARATION OF CANNABINOIDS BY SEQUENTIAL THIN LAYER CHROMATOGRAPHY.LOMBROZO L; KANTER SL; HOLLISTER LE et al.1976; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 15; NO 4; PP. 697-703; BIBL. 6 REF.Article

NATURA DELL' EFFETTO DELLA CAFFEINA SUGLI ENZIMICHE INTERVENGONO NEL METABOLISMO DEI FARMACI = NATURE DE L'EFFET DE LA CAFEINE SUR LES ENZYMES INTERVENANT DANS LE METABOLISME DES MEDICAMENTSMITOMA C; LOMBROZO L; LEVALLEY SE et al.1972; GAZZ. MED. ITAL.; ITAL.; DA. 1972; VOL. 131; NO 7-8; PP. 323-330; BIBL. 17 REF.Serial Issue

Functional tolerance to alprazolam-induced neurologic deficits in miceHENAUER, S. A; LOMBROZO, L; HOLLISTER, L. E et al.Life sciences (1973). 1984, Vol 35, Num 20, pp 2065-2070, issn 0024-3205Article

A microassay for measuring synaptosomal ³H-dopamine and ³H-metabolite releasePETRIE, E. C; LOMBROZO, L; CSERNANSKY, J. G et al.Brain research bulletin. 1990, Vol 25, Num 3, pp 423-427, issn 0361-9230, 5 p.Article

Circadian variations of lorazepam-induced neurologic deficitsHENAUER, S; LOMBROZO, L; HOLLISTER, L. E et al.Life sciences (1973). 1984, Vol 35, Num 22, pp 2193-2197, issn 0024-3205Article

Mood alteration following oral and intravenous haloperidol and relationship to drug concentration in normal subjectsMAGLIOZZI, J. R; GILLESPIE, H; LOMBROZO, L et al.Journal of clinical pharmacology. 1985, Vol 25, Num 4, pp 285-290, issn 0091-2700Article

Correlation of initial thiothixene serum levels and clinical response: comparison of fluorometric, gas chromatographic, and RBC assaysYESAVAGE, J. A; HOLMAN, C. A; COHN, R et al.Archives of general psychiatry. 1983, Vol 40, Num 3, pp 301-304, issn 0003-990XArticle

Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol : the effect of regular/intermittent dosingCSERNANSKY, J. G; BELLOWS, E. P; BARNES, D. E et al.Journal of reproduction and fertility. 1990, Vol 101, Num 4, pp 519-524, issn 0022-4251, 6 p.Article

Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administrationCSERNANSKY, J. G; BARNES, D. E; BELLOWS, E. P et al.Life sciences (1973). 1990, Vol 46, Num 10, pp 707-713, issn 0024-3205, 7 p.Article

Correlates of rapid neuroleptic response in male patients with schizophreniaPETRIE, E. C; FAUSTMAN, W. O; MOSES, J. A et al.Psychiatry research. 1990, Vol 33, Num 2, pp 171-177, issn 0165-1781, 7 p.Article

Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptomsCSERNANSKY, J. G; RINEY, S. J; LOMBROZO, L et al.Archives of general psychiatry. 1988, Vol 45, Num 7, pp 655-659, issn 0003-990XArticle

Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label studyCSERNANSKY, J. G; LOMBROZO, L; GULEVICH, G. D et al.Journal of clinical psychopharmacology. 1984, Vol 4, Num 6, pp 349-352, issn 0271-0749Article

Effects of raclopride treatment on plasma and CSF HVA : relationships with clinical improvement in male schizophrenicsCSERNANSKY, J. G; NEWCOMER, J. W; JACKSON, K et al.Psychopharmacologia. 1994, Vol 116, Num 3, pp 291-296, issn 0033-3158Article